Published June 13, 2022 | Version 1.0.0

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Janus kinase inhibitors for the treatment of COVID-19

Description

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Janus kinase inhibitors for the treatment of COVID-19.

Notes

This review is part of the CEOsys project funded by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF)), grant number 01KX2021.

Files